Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy
Roswell Park Cancer Institute
Roswell Park Cancer Institute
SkinJect, Inc.
Thomas Jefferson University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Brown University
National Cancer Institute (NCI)
The Methodist Hospital Research Institute
Bristol-Myers Squibb
Bristol-Myers Squibb
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC
University of California, San Francisco
University of Utah
University of Rochester
Eastern Cooperative Oncology Group
UNC Lineberger Comprehensive Cancer Center
Sotio Biotech Inc.
Iovance Biotherapeutics, Inc.
National Cancer Institute (NCI)
Mayo Clinic
Klein Buendel, Inc.
M.D. Anderson Cancer Center
Immunocore Ltd
AI Labs Group S.L
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Emory University
NYU Langone Health
Merck Sharp & Dohme LLC
Georgetown University
Pfizer
Eastern Cooperative Oncology Group
Dana-Farber Cancer Institute
Roswell Park Cancer Institute
Bristol-Myers Squibb
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Miami
Merck Sharp & Dohme LLC
MacroGenics
Sanofi
National Institutes of Health Clinical Center (CC)
University of California, Davis
Teva Branded Pharmaceutical Products R&D, Inc.
Genzada Pharmaceuticals USA, Inc.
Rutgers, The State University of New Jersey
Daiichi Sankyo